Improving beta‐cell secretory function and glycaemia in young‐onset type 2 diabetes: A pilot, 12‐month, randomized trial of a novel, continuous glucose monitor‐guided, rapid treatment intensification strategy incorporating empagliflozin and liraglutide. Issue 4 (28th December 2021) - Middleton, Timothy L.; Constantino, Maria I.; McGill, Margaret; D'Souza, Mario; Yue, Dennis K.; Twigg, Stephen M.; Wu, Ted; Wong, Jencia